Cipaglucosidase alfa Alternatives Compared
| Cipaglucosidase alfa | Lumizyme (alglucosidase alfa) | Pombiliti (cipaglucosidase alfa) |
|
|---|
| Cipaglucosidase alfa | Lumizyme (alglucosidase alfa) | Pombiliti (cipaglucosidase alfa) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Pompe Disease. Cipaglucosidase alfa may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Pompe Disease. Lumizyme may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Pompe Disease. Pombiliti may also be used for purposes not listed in this medication guide. |
Related suggestions Pompe Disease
|
|||||||||||||||
| More about Cipaglucosidase alfa | More about Lumizyme (alglucosidase alfa) | More about Pombiliti (cipaglucosidase alfa) | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
|
View all Cipaglucosidase alfa side effects |
View all Lumizyme side effects |
View all Pombiliti side effects |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Lumizyme prices |
View all Pombiliti prices |
||||||||||||||||
| Dosage Forms | ||||||||||||||||||
|
N/A |
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Pombiliti |
N/A |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
|
2.1 hours |
3.4 hours |
2.1 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category B
No proven risk in humans
Myozyme
Category C
Risk cannot be ruled out
Lumizyme See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 2 drugs are known to interact with Cipaglucosidase alfa:
|
A total of 1 drugs are known to interact with Lumizyme:
|
A total of 2 drugs are known to interact with Pombiliti:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
September 28, 2023 |
May 24, 2010 |
September 28, 2023 |
||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient Resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.